Condition: Metastatic Squamous Non-Small Cell Lung Cancer · Metastatic Nonsquamous Non-Small Cell Lung Cancer · Sponsor: Incyte Corporation
The purpose of this study is to assess the efficacy and safety of platinum-based chemotherapy with or without INCMGA00012 in participants with metastatic squamous and nonsquamous non-small cell lung cancer (NSCLC).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Pacific Cancer Medical Center | Anaheim, California, United States | — |
| Innovative Clinical Research Institute | Whittier, California, United States | — |
| Reading Hospital and Medical Center | Reading, Pennsylvania, United States | — |
| Fundacao Pio Xii Hospital de Cancer de Barretos | Barretos, Brazil | — |
| Incan - Instituto Do Cancer - Hospital Pompeia | Caxias do Sul, Brazil | — |
| Centro Regional Integrado de Oncologia | Fortaleza, Brazil | — |
| Oncosite - Centro de Pesquisa Clinica E Oncologia | Ijuí, Brazil | — |
| Clinica de Neoplasias Litoral Ltda | Itajaí, Brazil | — |
| Hospital Do Cancer de Londrina | Londrina, Brazil | — |
| Instituto Mederi de Pesquisa E Saude | Passo Fundo, Brazil | — |
| Hgb - Hospital Giovanni Battista - Mae de Deus Center | Porto Alegre, Brazil | — |
| Inca - Instituto Nacional de Cancer | Rio de Janeiro, Brazil | — |
+ 128 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.